Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27

United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$172.50M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$465.00M

$186.16M on a plan · $80.21M straight out of an exercise

Sold at will

$198.63M

42 of 260 sales

Net

−$292.51M

−$26.13M against sales at will